To Get Help Now
Click Here
 
Today's Date:

Consolidation Sought In Plavix Lawsuits

AddThis Social Bookmark Button

Plavix manufacturers Bristol-Myers Squibb and Sanofi-Aventis are seeking mass tort and consolidation of more than 40 cases filed in New Jersey state court, with the rumor of thousands more expected in the near future.

According to the lawsuits, Plavix, a popular drug used by people at risk of, or who have already suffered a heart attack, is no more effective than aspirin, yet is marketed as superior to aspirin therapies, and that the risks associated with Plavix far outweigh any benefit the drug might have. Lawsuits have also alleged that the FDA warned the drug makers not to market Plavix as better than aspirin back in 1998.

“We’re arguing Plavix has less efficacies than aspirin which is the generic and much cheaper and safer alternative that costs 4 cents a pill, compared to Plavix that sells for 4 dollars a pill,”  an attorney for plaintiffs told Lawyers USA.

Jurisdictions with a two-year statute of limitation only have until April 2012 to file complaints, so more lawsuits are expected to be seen across the nation in the coming months. In 2010, the Food and Drug Administration required the drug makers to place a black box warning on Plavix, alerting user to the increased risk of heart attack, stroke and potentially life threatening blood disorders.

 

breakinglawsuitnews.com disclaimer: This article: Consolidation Sought In Plavix Lawsuits was posted on Friday, May 20th, 2011 at 8:03 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.